Financials
- Market Capitalization 44.56 B
- Employee 883
- Founded 2014
- CEO N/A
- Website www.revmed.com
- Headquarter Delaware, United States
- FIGI BBG00829F4P8
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-13.39
Rapporto prezzo/fatturato
—
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 263 | ARGX argenx SE - American Depositary Shares | 1023.21 USD | -3.37% | -0.01% | +18.84% | +43.71% | 63.32 B USD | ||
| 296 | MRNA Moderna, Inc. - Common Stock | 137.99 USD | -3.35% | -3.30% | +146.94% | +476.64% | 55.09 B USD | ||
| 445 | ALNY Alnylam Pharmaceuticals, Inc. - Common Stock | 237.10 USD | +0.23% | +0.52% | +5.36% | -46.82% | 31.73 B USD | ||
| 488 | RPRX Royalty Pharma plc - Class A Ordinary Shares | 60.85 USD | -1.73% | -0.44% | +4.11% | +63.31% | 27.17 B USD |